retatrutide clinical trials retatrutide (RETA) GLP-3 Retatrutide (24mg vials) -

Disproportionate Impact of Obesity and Diabetes The Role of Financial Barriers Systemic and Structural Inequities Disproportionate Impact of Obesity and Diabetes

Fiorentino M, Bolignano D, Tesar V, Pisano A, Biesen WV, Tripepi G, et al

Below is a summary of the restrictions in place: Selling Retatrutide for personal use : It cannot be legally sold or supplied for human consumption or injection outside of approved research settings

Even less is known about how these reasons differ between those using GLP-1 RAs as anti-obesity medications (AOMs) versus those using them for antidiabetic management (ADMs), or how these patterns have changed over time as awareness, access, and prescribing practices have evolved

Compliance with Ethics Guidelines This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors